Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Intangibles: 2011-2019

Historic Intangibles for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Mar 2019 value amounting to $29.5 million.

  • EyePoint Pharmaceuticals' Intangibles fell 56.80% to $29.5 million in Q1 2019 from the same period last year, while for Mar 2019 it was $29.5 million, marking a year-over-year decrease of 56.80%. This contributed to the annual value of $68.3 million for FY2018, which is 91.86% up from last year.
  • EyePoint Pharmaceuticals' Intangibles amounted to $29.5 million in Q1 2019, which was down 56.80% from $68.3 million recorded in Q4 2018.
  • In the past 5 years, EyePoint Pharmaceuticals' Intangibles ranged from a high of $68.3 million in Q1 2018 and a low of $718,000 during Q4 2016.
  • Moreover, its 3-year median value for Intangibles was $36.3 million (2017), whereas its average is $47.2 million.
  • Its Intangibles has fluctuated over the past 5 years, first surged by 4,962.53% in 2017, then plummeted by 56.80% in 2019.
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' Intangibles stood at $1.5 million in 2015, then plummeted by 52.51% to $718,000 in 2016, then skyrocketed by 4,962.53% to $36.3 million in 2017, then spiked by 87.96% to $68.3 million in 2018, then tumbled by 56.80% to $29.5 million in 2019.
  • Its Intangibles stands at $29.5 million for Q1 2019, versus $68.3 million for Q4 2018 and $68.3 million for Q3 2018.